Authors' reply: Compassionate use of experimental drugs in the Ebola outbreak

The Lancet

Volumn 384, Issue 9957, 2014, Pages 1844-

  Rid, Annette ^a   Emanuel, Ezekiel J ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EBOLA VACCINE;

AFRICA; CLINICAL TRIAL (TOPIC); COMPASSIONATE USE; DRUG EFFICACY; DRUG SAFETY; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; EXPERIMENTAL THERAPY; HEALTH CARE; HEALTH PRACTITIONER; HUMAN; LETTER; PATIENT CARE; PRIORITY JOURNAL; THERAPY EFFECT; DISEASE OUTBREAKS; ETHICS; FEMALE; HEMORRHAGIC FEVER, EBOLA; MALE; HEALTH CARE SYSTEM;

DISEASE OUTBREAKS; FEMALE; HEMORRHAGIC FEVER, EBOLA; HUMANS; MALE; THERAPIES, INVESTIGATIONAL;

EID: 84925014235     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)62236-4     Document Type: Letter

References (5)

1. WHO Ebola Response Team. Ebola Virus disease in west Africa-The first 9 months of the epidemic and forward projections. N Engl J Med 2014;371:1481-95.
2. Jacob ST, Crozier I, Schieffelin JS, Colebunders R. Priorities for Ebola virus disease response in west Africa. Lancet 2014; published online Sept 25. http://dx.doi.org/10.1016/S0140-6736 (14) 61609-3.
3. Fauci AS. Ebola-underscoring the global disparities in health care resources. N Engl J Med 2014;371:1084-86.
4. Rid A, Emanuel EJ. Ethical considerations of experimental interventions in the Ebola outbreak. Lancet 2014;384:1896-99.
5. Folayan M, Brown B, Yakubu A, Peterson K, Haire B. Compassionate use of experimental drugs in the Ebola outbreak. Lancet 2014; published online Sept 12. http://dx.doi.org/10.1016/S0140-6736 (14) 61605-6.